• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Venus Remedies Limited — Important, 08-12-2025: Updates

    08-12-2025 | 10:58 am

    Venus Remedies received final €11 Cr from Cipla, completing AMR anti-infective licensing milestones in India. This product has delivered therapeutic benefits to over one million patients, validating the company's AMR-focused research.

    No comments yet. Be the first to comment!

    All announcements from Venus Remedies Limited